METHOTREXATE | OTTER PHARMS | ||
10MG/0.4ML (10MG/0.4ML),15MG/0.6ML (15MG/0.6ML),17.5MG/0.7ML (17.5MG/0.7ML),20MG/0.8ML (20MG/0.8ML),22.5MG/0.9ML (22.5MG/0.9ML),25MG/ML (25MG/ML) | |||
No | Yes | ||
Expired | Expired | ||
None | None | ||
None | No | ||
Otrexup PFS is a folate analog metabolic inhibitor indicated for the: • Management of patients with severe, active rheumatoid arthritis (RA) and polyarticular juvenile idiopathic arthritis (pJIA), who are intolerant of or had an inadequate response to first-line therapy. • Symptomatic control of severe, recalcitrant, disabling psoriasis in adults who are not adequately responsive to other forms of therapy. |
0 | 0 | 0 |
Total Other Developers | None |
---|
Drugs with Suitability | No |
---|
10MG/0.4ML (10MG/0.4ML) | ** | ** | - | - | - |
15MG/0.6ML (15MG/0.6ML) | ** | ** | - | - | - |
17.5MG/0.7ML (17.5MG/0.7ML) | ** | ** | - | - | - |
20MG/0.8ML (20MG/0.8ML) | ** | ** | - | - | - |
22.5MG/0.9ML (22.5MG/0.9ML) | ** | ** | - | - | - |
25MG/ML (25MG/ML) | ** | ** | - | - | - |
NDA Sales Available | Total Generic Sales Available |
---|---|
No | 0 |
ANDA No | Generic Co | Manufacturer Name | Operations | Manufacturer Address | Country |
---|
Download GenUS Drug Report
Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023
+91 94997 68112
nimish@researchdelta.com